NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sundry Debtors | ₹1,189 Cr | ₹856 Cr | ₹621 Cr | ₹413 Cr | ₹551 Cr |
What is the latest Sundry Debtors ratio of NATCO PHARMA ?
Year | Sundry Debtors |
---|---|
Mar2024 | ₹1,189 Cr |
Mar2023 | ₹856 Cr |
Mar2022 | ₹621 Cr |
Mar2021 | ₹413 Cr |
Mar2020 | ₹551 Cr |
How is Sundry Debtors of NATCO PHARMA Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2024 | ₹1,189 Cr | 38.87 | |
Mar2023 | ₹856 Cr | 37.95 | |
Mar2022 | ₹621 Cr | 50.30 | |
Mar2021 | ₹413 Cr | -25.10 | |
Mar2020 | ₹551 Cr | - |
Compare Sundry Debtors of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹21,044.3 Cr | -9.8% | -15.3% | 32% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -9.8% |
-15.3% |
32% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses